In another study, anti-PD-1 antibody was given to a mouse liver cancer model and 30 Gy SBRT radiotherapy was simultaneously administered, and the results showed that the infiltration level of CD8+ T cells in tumor tissue was significantly increased, the development of tumor was significantly inhibited, and the survival rate was also improved (32). This evidence concerns the gene CD8A and liver cancer.